Spero Therapeutics nabs Allergan executive — 3 insights

Spero Therapeutics appointed Ian Critchley, PhD, head of clinical microbiology.

Advertisement

Here’s what you should know.

1. Dr. Critchley will oversee Spero’s preclinical and clinical microbiology efforts.

2. He has more than 30 years of experience in anti-infective drug discovery.

3. Dr. Critchley most recently was Allergan’s vice president of clinical microbiology. At Allergan, he managed preclinical and clinical microbiology studies on anti-infective compounds.

More articles on supply chain:
Copper Ridge Surgery Center awarded for patient care initiative — 5 highlights
Acrometis and PriceMDs bring bundled pricing to workers’ comp space — 5 notes
Humana expands orthopedic bundled payment model to 7 more states

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply chain

Advertisement

Comments are closed.